MediLink Therapeutics (Suzhou) Co., Ltd.

Related records

Trials (23)

• A Clinical Study of YL205 in Patients With Advanced Solid Tumors
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
• A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
• A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
• A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC
• A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
• A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
• A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
• A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
• A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
• A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer
• A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
• A Study of YL201 in Patients With Advanced Solid Tumors
• A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy
• A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
• A Study of YL202 in Patients With Advanced Solid Tumors
• A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
• A Study of YL202 in Selected Patients With Advanced Solid Tumors
• A Study of YL242 in Subjects With Advanced Solid Tumors
• A Study YL201 in Patients With Selected Advanced Solid Tumors